Health Care · Pharmaceutical Preparations · Nasdaq · CIK 899460 · FYE Dec 31 · Prices AT CLOSE 2026-08-18 (USD) Last $4.07 · Day +4.36% · Mkt cap $1.3B · P/E (FY) 203.5× · 1Y +6.8% · Off 52W high −37.5% · Vol (1Y) 74.1% Price2023-08-18 → 2026-08-18 MNKD close: $4.98 on 2023-08-18 to $4.07 on 2026-08-18. Split-adj closes · 240 of 5,307 · price returnⓘ At a glance | Short interest8.7% of sh out | | Days to cover6.2d | | 13F net flow (QoQ)+4.02% | | Top-10 13F concentration58.4% | | Next report (est.)2026-11-04 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)203.5× | | Sales (TTM)$393.6M | | Earnings (TTM)-$43.6M | | Net margin1.7% | | Total debt / EBITDA6.94× | | Sales growth 3Y51.8% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−28.2% | | 1Y+6.8% | | 3Y−18.3% | | 5Y−0.2% | | 10Y−17.6% | | Since incept. (ann.)−11.4% |
Total return · from 2005-07-11ⓘ Risk | Ann. volatility (1Y)74.1% | | Ann. volatility (3Y)57.1% | | Sharpe (1Y)0.48 | | Sharpe (3Y)0.18 | | Max drawdown (1Y)−63.3% | | Max drawdown (3Y)−69.4% | | Beta (3Y vs SPY)1.28 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 28.6M | $70M | 9.28% | −1.2% | | STATE STREET CORP | 18.7M | $46M | 6.06% | +27.8% | | VANGUARD CAPITAL MANAGEMENT LLC | 12.9M | $32M | 4.18% | new | | UBS Group AG | 8.3M | $20M | 2.68% | +61.8% | | GEODE CAPITAL MANAGEMENT, LLC | 7.5M | $18M | 2.44% | +1.8% | | MILLENNIUM MANAGEMENT LLC | 6.4M | $16M | 2.07% | +1146.4% | | Frazier Life Sciences Management, L.P. | 5.9M | $14M | 1.91% | +39.6% | | MORGAN STANLEY | 5.8M | $14M | 1.88% | +30.4% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-05 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-05 | −$0.06 | — | $109.4M | +42.9% | | 2026-03-31 | 2026-05-06 | −$0.05 | −225.0% | $90.2M | +15.1% | | 2025-12-31 | 2026-02-26 | — | — | $112.0M | +45.8% | | 2025-09-30 | 2025-11-05 | $0.03 | −25.0% | $82.1M | +17.2% |
As-reported XBRL · next 2026-11-04 est.ⓘ Segment mixFY2025 (ended Dec 2025) All Other Segments 100% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
